Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA

Biotechnology

Health Care

Life Sciences

Therapeutics

Tacalyx

Tacalyx's headquarters in Berlin, Germany

Peter Sondermann

Matthias Ocker

Frank Hensel

Ulrich Mahr

Peter Neubeck

Sebastian Pünzeler

Karlheinz Schmelig

Klaus Schollmeier

Peter Seeberger

Alexander Ehlgen

The Board Members at Tacalyx are responsible for providing strategic guidance, overseeing the company's governance, and ensuring the effective execution of its mission to discover and develop novel anti-TACA therapies. Their collective expertise helps steer the company towards sustainable growth and scientific innovation.

Board Members

The Scientific Research and Development team at Tacalyx is dedicated to advancing the discovery and development of novel anti-TACA therapies. This team leverages expertise in chemistry, antibody and protein sciences, cell biology, and experimental medicine to conduct cutting-edge research and translate scientific discoveries into potential therapeutic treatments.

Scientific Research and Development

The Leadership Team at Tacalyx is responsible for setting the strategic vision and direction of the company, overseeing the discovery and development of innovative anti-TACA therapeutics. Comprised of the co-founders and the CEO, this team drives corporate governance, fosters partnerships, and ensures the alignment of research initiatives with the company's goals for advancing biotech solutions.

Tacalyx

Org chart

Board & advisors

Teams

Board Members

Scientific Research and Development

Leadership Team

Offices

Tacalyx

Org chart

Board & advisors

Teams

Board Members

Scientific Research and Development

Leadership Team

Offices

Related companies